Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in creating active pharmaceutical ingredients (APIs) that target specific signaling pathways in oncology research. Its structure allows for selective modification, enabling optimization of drug potency and selectivity. Also employed in the preparation of antiviral agents and in medicinal chemistry research for designing novel heterocyclic compounds with biological activity.